Exercise capacity in idiopathic pulmonary fibrosis: The effect of pulmonary hypertension

Respirology

Volumn 16, Issue 3, 2011, Pages 451-458

  Boutou, Afroditi K ^a   Pitsiou, Georgia G ^a   Trigonis, Ioannis ^a   Papakosta, Despina ^a   Kontou, Paschalina K ^a   Chavouzis, Nikolaos ^a   Nakou, Chrysanthi ^a   Argyropoulou, Paraskevi ^a   Wasserman, Karlman ^b   Stanopoulos, Ioannis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Echocardiography; Exercise test; Idiopathic pulmonary fibrosis; Pulmonary hypertension; Spirometry

Indexed keywords

ADULT; AGED; ANAEROBIC THRESHOLD; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; EXERCISE; FEMALE; FIBROSING ALVEOLITIS; HUMAN; INTERMETHOD COMPARISON; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY;

ADULT; ANAEROBIC THRESHOLD; EXERCISE; EXERCISE TEST; FEMALE; HEART CATHETERIZATION; HEART RATE; HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PHYSICAL ENDURANCE; RETROSPECTIVE STUDIES;

EID: 79953288266     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01909.x     Document Type: Article

References (35)

1. Nadrous HF, Pellikka PA, Krowka MJ et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005; 128: 2393-9. (Pubitemid 41507585)
2. Shorr AF,Wainright JL, Cors CS et al. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur. Respir. J. 2007; 30: 715-21.
3. Lettieri CJ, Nathan SD, Barnett SD et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129: 746-52.
4. Daniels CE, Yi ES, Ryu JH. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Eur. Respir. J. 2008; 32: 170-4.
5. Nathan SD, Noble PW, Tuder RM. Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am. J. Respir. Crit. Care Med. 2007; 175: 875-80.
6. Kawut SM, O'Shea MK, Bartels MN et al. Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir.Med. 2005; 99: 1431-9. (Pubitemid 41487501)
7. Nathan SD, Shlobin OA, Ahmad S et al. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007; 131: 657-63. (Pubitemid 46446854)
8. Hansen JE, Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest 1996; 109: 1566-76. (Pubitemid 26193386)
9. Ferrazza AM, Martolini D, Valli G et al. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration 2009; 77: 3-17.
10. Markovitz GH, Cooper CB. Exercise and interstitial lung disease. Curr. Opin. Pulm.Med. 1998; 4: 272-80.
11. Glaser S, Noga O, Koch B et al. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir.Med. 2009; 103: 317-24.
12. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 2000; 161: 646-64.
13. Clark EH,Woods RL, Hughes JMB. Effect of blood transfusion on the carbon monoxide transfer factor of the lung in man. Clin. Sci. Mol.Med. 1978; 54: 627-31.
14. Wasserman K, Hansen J, Sue DY et al. Principles of Exercise Testing and Interpretation, 4th edn. Lippincott Williams & Wilkins, Philadelphia, 2005.
15. Schiller NB. Pulmonary artery pressure estimation by Doppler and two-dimensional echocardiography. Cardiol. Clin. 1990; 8: 277-87.
16. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC), European Respiratory Society (ERS), International Society of Heart, Lung Transplantation (ISHLT), Galiè N, Hoeper MM, HumbertMet al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J. 2009; 34: 1219-63.
17. Schiller NB. Two-dimensional echocardiographic determination of left ventricular volume, systolic function and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation. 1991; 83 (3 Suppl.): 1280-7.
18. American Thoracic Society/American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 2003; 167: 211-77.
19. Beaver WL,Wasserman K, Whipp BJ. A new method for detecting the anaerobic threshold by gas exchange. J. Appl. Physiol. 1986; 60: 2020-7.
20. Knudson RJ, Lebowitz MD, Holberg CJ et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am. Rev. Respir. Dis. 1983; 127: 725-34.
21. Cotes JE. Lung Function, 3rd edn. Blackwell, Oxford, 1975. 384-90.
22. Field AP. Discovering Statistics Using SPSS for Windows. Cromwell Press Ltd, Great Britain, 2000.
23. Portney LG,Watkins MP. Foundations of Clinical Research:Applications to Practice, 2nd edn. Prentice-Hall Inc., Upper Sandle River, NJ, 2000.
24. Arcasoy SM, Christie JD, Ferrari VA et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am. J. Respir. Crit. Care Med. 2003; 167: 735-40.
25. Tolle JJ, Waxman AB, Van Horn TL et al. Exercise-induced pulmonary arterial hypertension. Circulation 2008; 118: 2183-9.
26. Barst R, McGoon M, Torbicki A et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 2004; 43: 40-7.
27. Nathan SD, Shlobin OA, Barnett SD et al. Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir. Med. 2008; 102: 1305-10.
28. Ting H, Sun X-G, Chuang M-L et al. A noninvasive assessment of pulmonary perfusion abnormality in patients with primary pulmonary hypertension. Chest 2001; 119: 824-32. (Pubitemid 32197655)
29. Vonbank K, Funk GC,Marzluf B et al. Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD. Wien Klin.Wochenschr. 2008; 120: 749-55.
30. Reindl I, Wernecke KD, Opitz C et al. Impaired ventilatory efficiency in chronic heart failure: Possible role of pulmonary vasoconstriction. Am. Heart J. 1998; 136: 778-85.
31. Theodore J, Robin ED, Morris AJR et al. Augmented ventilatory response to exercise in pulmonary hypertension. Chest 1986; 89: 39-44. (Pubitemid 16187110)
32. Patel NM, Lederer DJ, Borczuk AC et al. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 2007; 132: 998-1006.
33. Juilliere Y, Barbier G, Feldmann L et al. Additional predictive value of both left and right ventricular ejection fractions on longterm survival in idiopathic dilated cardiomyopathy. Eur. Heart J. 1997; 18: 276-80.
34. López-Candales A, Dohi K, Iliescu A et al. An abnormal right ventricular apical angle is indicative of global right ventricular impairment. Echocardiography 2006; 23: 361-8. (Pubitemid 43943840)
35. Lama VN, Flaherty KR, Toews GB et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2003; 168: 1084-90.